Evidence map›Paper›PMID 30587955›Full record

Trial reportInternational journal of chronic obstructive pulmonary disease

Automated oxygen control with O2matic

Ejvind Frausing Hansen, Jens Dahlgaard Hove, Charlotte Sandau Bech, Jens-Ulrik Stæhr Jensen, Thomas Kallemose, Jørgen Vestbo

7 registry-linked trialsOpen access · goldAbstract readComparative StudyRandomized Controlled TrialVideo-Audio Media
In one paragraph

Trial report in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03464695 nacompletednot on this map

Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD

TypeinterventionalSponsorHvidovre University HospitalRan2018 to 2018Enrolled20ConditionsCOPD Exacerbation, Hypoxia, Hyperoxia, Respiratory FailureArmsO2matic
NCT03661086 nacompletednot on this map

Oxygen Control and Weaning by O2matic to Patients Admitted With an Exacerbation of COPD

TypeinterventionalSponsorHvidovre University HospitalRan2018 to 2022Enrolled157ConditionsCOPD Exacerbation, Hypoxia, Hypoxemia, HyperoxiaArmsO2matic
NCT04079465 nacompletednot on this map

Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia

TypeinterventionalSponsorHvidovre University HospitalRan2019 to 2023Enrolled30ConditionsHypoxemic Respiratory Failure, Hypoxia, Hypoxemia, Respiratory FailureArmsO2matic
NCT04123730 nacompletednot on this map

Automated Oxygen Titration With O2matic During Walking in Patients With COPD

TypeinterventionalSponsorHvidovre University HospitalRan2019 to 2020Enrolled35ConditionsChronic Obstructive Pulmonary Disease, Respiratory FailureArmsFixed-dose compared to variable oxygen flow supplementation during walking
NCT05452863 nacompletednot on this map

Automatic Oxygen Supply With the O2matic Device for the Treatment of Hospitalized Heart Patients With Hypoxia

TypeinterventionalSponsorHvidovre University HospitalRan2022 to 2024Enrolled60ConditionsHeart DiseasesArmsO2matic administered oxygen, Manual oxygen supply and adjustments
NCT06465654 nacompletednot on this map

OXYWILD - Automated Oxygen Titration With O2matic During Walking in Patients With Fibrotic Interstitial Lung Diseases (F-ILD): A Randomized Study

TypeinterventionalSponsorJanne Hastrup JensenRan2024 to 2025Enrolled29ConditionsFibrosis Lung, Respiratory TherapyArmsAutomated variable dose oxygen treatment, Fixed dose oxygen treatment
NCT07576946 active not recruitingnot on this map

Development and Pilot Evaluation of an Artificial Intelligence-Assisted System for Automated Oxygen Flow Regulation: The Saturista Device

TypeobservationalSponsorKoç UniversityRan2026 to 2026Enrolled7ConditionsOxygen Therapy
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ejvind Frausing HansenMedical Unit, Amager and Hvidovre Hospital, Copenhagen, Denmark, ejvind.frausing.hansen@regionh.dk.
Jens Dahlgaard HoveMedical Unit, Amager and Hvidovre Hospital, Copenhagen, Denmark, ejvind.frausing.hansen@regionh.dk.
Charlotte Sandau BechMedical Unit, Amager and Hvidovre Hospital, Copenhagen, Denmark, ejvind.frausing.hansen@regionh.dk.
Jens-Ulrik Stæhr JensenMedical Department, Herlev and Gentofte Hospital, Copenhagen, Denmark.
Thomas KallemoseClinical Research Center, Amager and Hvidovre Hospital, Copenhagen, Denmark.
Jørgen VestboSchool of Biological Sciences, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
Amager Hospital · DKGentofte Hospital · DKManchester University NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIt is a challenge to control oxygen saturation (SpO PATIENTS AND

methodsWe conducted a crossover trial with patients admitted with an exacerbation of COPD and hypoxemia (SpO

resultsTwenty patients were randomized and 19 completed the study. Mean age was 72.4 years and mean FEV

conclusionO2matic was able to effectively control SpO

Indexed as

Patient AdmissionAgedAged, 80 and overAutomationCross-Over StudiesDenmarkDisease ProgressionEquipment DesignFemaleForced Expiratory VolumeHumansLungMaleMiddle AgedOximetryOxygen Inhalation Therapyclosed-loophyperoxiahypoxiaoxygen saturationoxygen therapy

Identifiers

PMID30587955
PMCPMC6300382
OpenAlexW2904696820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.